Interius is a preclinical stage company expanding the potential of gene therapy by reengineering viral vectors to drive cell-specific therapy.
Location: United States, Pennsylvania, Philadelphia
Phone: +52 958 117 1026
Total raised: $76M
Investors 7
Funding Rounds 1
| Date | Series | Amount | Investors |
| 19.05.2021 | Series A | $76M | - |
Mentions in press and media 5
| Date | Title | Description | Source |
| 18.05.2021 | Interius BioTherapeutics Raises $76M in Series A Financing | Interius BioTherapeutics, a Philadelphia, PA-based preclinical stage gene therapy company developing... | finsmes.co... |
| 18.05.2021 | Interius BioTherapeutics Raises $76M Series A Financing to A... | prnewswire... | |
| 27.07.2012 | Fundraising: Gene therapy firm targeting sickle cell anemia ... | Product: Gene therapy to target sickle cell anemia, beta-thalassemia and childhood cerebral adrenole... | medcitynew... |
| - | Interius BioTherapeutics Raises $76M Series A Financing to A... | PHILADELPHIA, May 18, 2021 /PRNewswire/ -- Interius BioTherapeutics, a preclinical stage gene therap... | acsbrighte... |
| - | Fundraising: Gene therapy firm targeting sickle cell anemia ... | Company name: bluebird bio. Industry: Biotechnology. Location: Cambridge, Massachusetts. Product: Ge... | medcitynew... |